Aditxt, Inc. (NASDAQ:ADTX) Sees Large Decrease in Short Interest

Aditxt, Inc. (NASDAQ:ADTXGet Free Report) saw a large drop in short interest during the month of May. As of May 15th, there was short interest totaling 91,437 shares, a drop of 62.6% from the April 30th total of 244,575 shares. Based on an average daily volume of 5,980,521 shares, the short-interest ratio is presently 0.0 days. Currently, 277.1% of the company’s shares are short sold.

Aditxt Stock Performance

Shares of Aditxt stock opened at $0.12 on Friday. The stock has a market capitalization of $96,104.00, a PE ratio of 0.00 and a beta of 1.08. Aditxt has a 52-week low of $0.11 and a 52-week high of $53,451.08. The company has a 50-day simple moving average of $10.77 and a two-hundred day simple moving average of $218.09.

Aditxt (NASDAQ:ADTXGet Free Report) last issued its earnings results on Tuesday, March 31st. The company reported $315,563.31 earnings per share (EPS) for the quarter. Aditxt had a negative net margin of 360,152.50% and a negative return on equity of 374.60%.

Analyst Ratings Changes

Several research firms have recently commented on ADTX. Wall Street Zen raised shares of Aditxt to a “sell” rating in a research report on Saturday, May 23rd. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Aditxt in a report on Monday, April 20th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company has an average rating of “Sell”.

Get Our Latest Analysis on Aditxt

Aditxt Company Profile

(Get Free Report)

Aditxt, Inc is a clinical-stage biotechnology company focused on the development and commercialization of natural antimicrobial peptides and microbiome-based detection technologies. Leveraging proprietary peptide libraries, the company aims to provide novel solutions for infection prevention and control across healthcare, food safety, animal health and agricultural markets. Aditxt’s approach centers on harnessing peptides that can disrupt microbial cell membranes without promoting resistance, addressing a growing need for alternatives to traditional antibiotics and chemical disinfectants.

The company’s product offerings include contract-based microbial detection and identification services, designed to help hospitals, food processors and other regulated industries monitor contamination levels and validate hygiene protocols.

Recommended Stories

Receive News & Ratings for Aditxt Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aditxt and related companies with MarketBeat.com's FREE daily email newsletter.